CURE vs. CNRG
Compare and contrast key facts about Direxion Daily Healthcare Bull 3x Shares (CURE) and SPDR S&P Kensho Clean Power ETF (CNRG).
CURE and CNRG are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. CURE is a passively managed fund by Direxion that tracks the performance of the Health Care Select Sector Index (300%). It was launched on Jun 15, 2011. CNRG is a passively managed fund by State Street that tracks the performance of the S&P Kensho Clean Power Index. It was launched on Oct 22, 2018. Both CURE and CNRG are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: CURE or CNRG.
Key characteristics
| CURE | CNRG | |
|---|---|---|
| YTD Return | 3.78% | -17.58% |
| 1Y Return | 5.96% | -26.65% |
| 3Y Return (Ann) | 4.07% | -17.84% |
| 5Y Return (Ann) | 16.84% | 12.26% |
| Sharpe Ratio | 0.23 | -0.86 |
| Daily Std Dev | 31.45% | 29.07% |
| Max Drawdown | -69.19% | -59.60% |
| Current Drawdown | -26.56% | -58.28% |
Correlation
The correlation between CURE and CNRG is 0.43, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
CURE vs. CNRG - Performance Comparison
In the year-to-date period, CURE achieves a 3.78% return, which is significantly higher than CNRG's -17.58% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
CURE vs. CNRG - Expense Ratio Comparison
CURE has a 1.08% expense ratio, which is higher than CNRG's 0.45% expense ratio.
Risk-Adjusted Performance
CURE vs. CNRG - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Direxion Daily Healthcare Bull 3x Shares (CURE) and SPDR S&P Kensho Clean Power ETF (CNRG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
CURE vs. CNRG - Dividend Comparison
CURE's dividend yield for the trailing twelve months is around 1.82%, more than CNRG's 1.49% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CURE Direxion Daily Healthcare Bull 3x Shares | 1.82% | 2.02% | 0.38% | 0.02% | 0.17% | 0.40% | 0.70% | 0.18% | 0.00% | 0.00% | 0.00% | 1.24% |
CNRG SPDR S&P Kensho Clean Power ETF | 1.49% | 1.17% | 1.23% | 1.34% | 0.69% | 1.16% | 0.35% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
CURE vs. CNRG - Drawdown Comparison
The maximum CURE drawdown since its inception was -69.19%, which is greater than CNRG's maximum drawdown of -59.60%. Use the drawdown chart below to compare losses from any high point for CURE and CNRG. For additional features, visit the drawdowns tool.
Volatility
CURE vs. CNRG - Volatility Comparison
Direxion Daily Healthcare Bull 3x Shares (CURE) has a higher volatility of 10.19% compared to SPDR S&P Kensho Clean Power ETF (CNRG) at 7.06%. This indicates that CURE's price experiences larger fluctuations and is considered to be riskier than CNRG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.